001     130534
005     20240228143441.0
024 7 _ |a 10.1016/j.cell.2015.12.033
|2 doi
024 7 _ |a pmid:26871632
|2 pmid
024 7 _ |a pmc:PMC4752822
|2 pmc
024 7 _ |a 0092-8674
|2 ISSN
024 7 _ |a 1097-4172
|2 ISSN
024 7 _ |a altmetric:5373906
|2 altmetric
037 _ _ |a DKFZ-2017-05613
041 _ _ |a eng
082 _ _ |a 570
100 1 _ |a Scognamiglio, Roberta
|0 P:(DE-He78)e71131deb6a162322ed90cb14da7a50e
|b 0
|e First author
|u dkfz
245 _ _ |a Myc Depletion Induces a Pluripotent Dormant State Mimicking Diapause.
260 _ _ |a [Cambridge, Mass.]
|c 2016
|b Cell Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1521188162_1657
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Mouse embryonic stem cells (ESCs) are maintained in a naive ground state of pluripotency in the presence of MEK and GSK3 inhibitors. Here, we show that ground-state ESCs express low Myc levels. Deletion of both c-myc and N-myc (dKO) or pharmacological inhibition of Myc activity strongly decreases transcription, splicing, and protein synthesis, leading to proliferation arrest. This process is reversible and occurs without affecting pluripotency, suggesting that Myc-depleted stem cells enter a state of dormancy similar to embryonic diapause. Indeed, c-Myc is depleted in diapaused blastocysts, and the differential expression signatures of dKO ESCs and diapaused epiblasts are remarkably similar. Following Myc inhibition, pre-implantation blastocysts enter biosynthetic dormancy but can progress through their normal developmental program after transfer into pseudo-pregnant recipients. Our study shows that Myc controls the biosynthetic machinery of stem cells without affecting their potency, thus regulating their entry and exit from the dormant state.
536 _ _ |a 311 - Signalling pathways, cell and tumor biology (POF3-311)
|0 G:(DE-HGF)POF3-311
|c POF3-311
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Myc protein, mouse
|2 NLM Chemicals
650 _ 7 |a Proto-Oncogene Proteins c-myc
|2 NLM Chemicals
700 1 _ |a Cabezas-Wallscheid, Nina
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Thier, Marc
|0 P:(DE-He78)6257f38db66cdb3a0d6fdab856728545
|b 2
|u dkfz
700 1 _ |a Altamura, Sandro
|b 3
700 1 _ |a Reyes, Alejandro
|b 4
700 1 _ |a Prendergast, Aine
|0 P:(DE-He78)a071b452400f4a34fc58fa5db64b3012
|b 5
|u dkfz
700 1 _ |a Baumgärtner, Daniel
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Carnevalli, Larissa S
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Atzberger, Ann
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Haas, Simon
|0 P:(DE-He78)a5ec4e2fef99022a37a6b07c2fdd6325
|b 9
|u dkfz
700 1 _ |a von Paleske, Lisa
|0 P:(DE-He78)ad009253d266295ec14c8cb708d87163
|b 10
|u dkfz
700 1 _ |a Boroviak, Thorsten
|b 11
700 1 _ |a Wörsdörfer, Philipp
|b 12
700 1 _ |a Essers, Marieke
|0 P:(DE-He78)ba3fae49054b6bfaaa289b05ecd936d6
|b 13
|u dkfz
700 1 _ |a Kloz, Ulrich
|0 P:(DE-He78)1a5f84c92367a0ab8dffdd2d3619e234
|b 14
|u dkfz
700 1 _ |a Eisenman, Robert N
|b 15
700 1 _ |a Edenhofer, Frank
|b 16
700 1 _ |a Bertone, Paul
|b 17
700 1 _ |a Huber, Wolfgang
|b 18
700 1 _ |a van der Hoeven, Franciscus
|0 P:(DE-He78)db41d10e17712fc21628c50a14f4d507
|b 19
|u dkfz
700 1 _ |a Smith, Austin
|b 20
700 1 _ |a Trumpp, Andreas
|0 P:(DE-He78)732f4fbcddb0042251aa759a2e74d3b2
|b 21
|e Last author
|u dkfz
773 _ _ |a 10.1016/j.cell.2015.12.033
|g Vol. 164, no. 4, p. 668 - 680
|0 PERI:(DE-600)2001951-8
|n 4
|p 668 - 680
|t Cell
|v 164
|y 2016
|x 0092-8674
909 C O |o oai:inrepo02.dkfz.de:130534
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)e71131deb6a162322ed90cb14da7a50e
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)6257f38db66cdb3a0d6fdab856728545
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)a071b452400f4a34fc58fa5db64b3012
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)a5ec4e2fef99022a37a6b07c2fdd6325
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)ad009253d266295ec14c8cb708d87163
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)ba3fae49054b6bfaaa289b05ecd936d6
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-He78)1a5f84c92367a0ab8dffdd2d3619e234
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 19
|6 P:(DE-He78)db41d10e17712fc21628c50a14f4d507
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 21
|6 P:(DE-He78)732f4fbcddb0042251aa759a2e74d3b2
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-311
|2 G:(DE-HGF)POF3-300
|v Signalling pathways, cell and tumor biology
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2016
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CELL : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 25
|0 StatID:(DE-HGF)9925
|2 StatID
|b CELL : 2015
920 1 _ |0 I:(DE-He78)V960-20160331
|k V960
|l HI-Stem
|x 0
920 1 _ |0 I:(DE-He78)A010-20160331
|k A010
|l Stammzellen und Krebs
|x 1
920 1 _ |0 I:(DE-He78)A011-20160331
|k A011
|l Stressinduzierte Aktivierung von hämatopoetischen Stammzellen
|x 2
920 1 _ |0 I:(DE-He78)W450-20160331
|k W450
|l Transgen-Service
|x 3
920 1 _ |0 I:(DE-He78)L101-20160331
|k L101
|l DKTK Heidelberg
|x 4
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)V960-20160331
980 _ _ |a I:(DE-He78)A010-20160331
980 _ _ |a I:(DE-He78)A011-20160331
980 _ _ |a I:(DE-He78)W450-20160331
980 _ _ |a I:(DE-He78)L101-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21